SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.61    0.41 (18.64%)
Bid:
2.62
Ask:
2.90
Spread: 0.28 (10.687%)
Market Cap: £4.76m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

Litigation update

12 Jan 2026 07:00

RNS Number : 4691O
Nanoco Group PLC
12 January 2026
 

FOR IMMEDIATE RELEASE 12 January 2026

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (596/2014/EU) AS THE SAME HAS BEEN RETAINED IN UK LAW AS AMENDED BY THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK MAR").

Nanoco Group PLC

("Nanoco", the "Group", or the "Company")

 

Litigation update

 

Nanoco seeks damages for infringement of IP by Shoei

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from its technology platform has filed an answer and counterclaims to the complaint for declaratory judgement originally filed by Shoei Chemical Inc. and Shoei Electronic Materials, Inc. (together, "Shoei") in the US District Court for the Eastern District of Virginia.

As detailed in the Group announcement on 27 November 2025, Shoei filed a declaratory judgement action claiming it is not infringing a number of Nanoco's patents.

Subsequently, the Board has evaluated next steps with legal counsel and concluded that it has a number of counterclaims against Shoei for infringement of Nanoco's intellectual property. As part of the counterclaims, Nanoco seeks damages for infringement of U.S. Patent No. 7,588,828, US Patent No. 7,803,423, US Patent No. 7,867,557 and US Patent No. 8,524,365.

Shoei acquired substantially all of the assets from Nanosys, Inc. ("Nanosys"), another manufacturer of quantum dots, for an undisclosed sum in September 2023. Shoei is a supplier of quantum dots to a number of globally significant technology companies. At this stage, the counterclaims do not specify the quantum of monetary damages sought by Nanoco and it may take some time before this is established.

Nanoco has retained Caldwell, Cassady and Curry ("CCC"), an IP law firm based in Dallas, Texas, USA, to represent it in patent enforcement and litigation. CCC was one of the legal firms involved in Nanoco's successful litigation against both Samsung and LG Electronics.

This case is expected to come to trial within the calendar year 2026 and is currently being funded from the Group's existing cash reserves. Shareholders are reminded that there can be no guarantee of success in a lawsuit, or as to the monetary damages that may be awarded if the jury and/or court finds in favour of Nanoco.

The Board of Nanoco will continue to update shareholders as appropriate.

 

Dr Jalal Bagherli, Nanoco's Chairman, commented:

"Nanoco has on multiple occasions proven the value and validity of its IP through the Samsung and LG litigation processes. As a Board, we have been clear in our commitment to defending our IP to ensure a fair outcome for shareholders of Nanoco, and have the financial resources to do so.

 

As with previous litigation that the Board has overseen, while there is potential for damages, litigation itself carries considerable inherent risk and the Board must weigh the opportunity versus the cost. Having taken legal advice and given Shoei's position in the global technology supply chain, the Board believes that it is in the best interests of shareholders to both defend the Shoei claims of non-infringement, and pursue counter claims for infringement.

 

 

- Ends -

MAR

The information contained within this announcement is considered by the Company to contain inside information for the purposes of UK MAR. Upon the publication of this announcement via a Regulatory Information Service, this inside information will be considered to be in the public domain.

The person responsible for arranging for the release of this announcement on behalf of Nanoco is Liam Gray, Chief Financial Officer.

 

Nanoco Group plc:

Dmitry Shashkov, CEO +44 (0)1928 761 404

Liam Gray, CFO & Company Secretary

 

Sodali & Co (Public Relations)

Elly Williamson +44 (0)79 3535 1934

Pete Lambie

Oliver Banks

Nanoco@sodali.com

 

Cavendish Capital Markets Limited (Financial Adviser and Corporate Broker):

Ed Frisby / George Lawson (Corporate Finance) +44 (0) 20 7220 0500

Tim Redfern (Corporate Broking)

Jasper Berry (Sales)

 

Notes for editors:

About Nanoco Group plc

Nanoco (LSE: NANO) is a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from its technology platform. In particular, Nanoco is a nanomaterial production and licensing group, specialising in the production of its patented cadmium free quantum dots (CFQD® materials) and other patented nanomaterials for use in the electronics industries. Founded in 2001 and headquartered in Runcorn, UK, Nanoco continues to build out a world-class, patent-protected IP portfolio alongside its existing scaled up production facilities for commercial orders.

Nanomaterials are materials with dimensions typically in the range 1 - 100 nm. Nanomaterials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nanomaterial that have size-dependent optical and electronic properties. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Sensor, Electronics and Display markets. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of display applications. Nanoco's HEATWAVE® quantum dots can be tuned to absorb light at different wavelengths across the near-infrared spectra, rendering them useful for applications including cameras and image sensors.

Nanoco is listed on the Main Market of the London Stock Exchange, holds the LSE's Green Economy Mark, and trades under the ticker symbol NANO. For further information please visit: www.nanocotechnologies.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFFFAFEMSEDF
Date   Source Headline
1st Dec 202112:30 pmRNSDirector/PDMR Shareholding
1st Dec 202112:28 pmRNSAnnual General Meeting – Voting Results
30th Nov 20217:00 amRNSAGM Statement
18th Nov 20211:13 pmRNSDirector/PDMR Shareholding
9th Nov 20217:11 amRNSDirector/PDMR Shareholding
8th Nov 20217:00 amRNSDirector Appointment
5th Nov 202111:25 amRNSAdditional Work Package for European Customer
4th Nov 20216:20 pmRNSNotice of AGM
3rd Nov 20217:00 amRNSPreliminary Results
18th Oct 20216:10 pmRNSChange to final results announcement date
13th Oct 20219:30 amRNSPresentation via Investor Meet Company
8th Oct 20211:48 pmRNSNotice of Results
19th Aug 20217:00 amRNSNon-Executive Director Appointment
16th Jul 20214:41 pmRNSSecond Price Monitoring Extn
16th Jul 20214:35 pmRNSPrice Monitoring Extension
15th Jul 20217:00 amRNSNon-dilutive loan note subscription
5th Jul 20217:30 amRNSDevelopment Agreement
28th Jun 20217:00 amRNSLitigation update and non-dilutive debt facility
10th Jun 202111:33 amRNSBlocklisting Six-Monthly Return
24th May 202112:20 pmRNSHolding(s) in Company
20th May 20217:00 amRNSLitigation Update
13th May 20217:00 amRNSProject Extension
12th May 20217:00 amRNSLitigation Update
6th May 20213:28 pmRNSHolding(s) in Company
30th Mar 20217:00 amRNSInterim Results
29th Mar 20217:00 amRNSLitigation Update
26th Mar 20214:41 pmRNSSecond Price Monitoring Extn
26th Mar 20214:36 pmRNSPrice Monitoring Extension
24th Mar 20213:36 pmRNSAmendment to Executive Director Service Terms
16th Mar 20212:30 pmRNSNotice of Results
10th Feb 20214:40 pmRNSSecond Price Monitoring Extn
10th Feb 20214:35 pmRNSPrice Monitoring Extension
25th Jan 20214:41 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
29th Dec 20204:41 pmRNSSecond Price Monitoring Extn
29th Dec 20204:36 pmRNSPrice Monitoring Extension
21st Dec 20207:00 amRNSDirector/PDMR Shareholding
11th Dec 202011:40 amRNSBlocklisting Six-Monthly Return
3rd Dec 202012:10 pmRNSResult of AGM
3rd Dec 20207:00 amRNSAGM Statement
25th Nov 20207:00 amRNSGrant Funding Award for Life Sciences Project
17th Nov 20205:50 pmRNS2020 Annual Report and Notice of AGM
22nd Oct 20204:40 pmRNSSecond Price Monitoring Extn
22nd Oct 20204:35 pmRNSPrice Monitoring Extension
21st Oct 20203:16 pmRNSDirector/PDMR Shareholding
13th Oct 20207:00 amRNSPreliminary Results
7th Oct 20207:00 amRNSNotice of Results
25th Sep 20204:36 pmRNSPrice Monitoring Extension
1st Sep 20207:00 amRNSDirectorate Changes
21st Jul 202011:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.